Download PDF

Other users also viewed these articles

Treatment adherence in patients with multiple sclerosis: risk factors L.A. Rodríguez de Antonio; R. Fernández de Córdoba-García; N. Herrero-Muñoz; A. Ontañón-Nasarre; I. García-Castañón;
Neurologia. 2025;40:353-60
A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis E.J. Ramos González; L.J. Ramirez Jirano; D.Z. García Martínez; G.G. Ortiz; L.F. Jave Suárez; C.A. Leal Cortes; O.K. Bitzer Quintero;
Neurologia. 2021;36:262-70
Cognitive rehabilitation program in patients with multiple sclerosis: A pilot study R.M. Jiménez-Morales; Y. Broche-Pérez; Y. Macías-Delgado; C. Sebrango; S. Díaz-Díaz; R. Castiñeira-Rodriguez; F.J. Pérez-González; C. Forn;
Neurologia. 2024;39:135-46